Cargando…
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
[Image: see text] Drug development has a high attrition rate, with poor pharmacokinetic and safety properties a significant hurdle. Computational approaches may help minimize these risks. We have developed a novel approach (pkCSM) which uses graph-based signatures to develop predictive models of cen...
Autores principales: | Pires, Douglas E. V., Blundell, Tom L., Ascher, David B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2015
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434528/ https://www.ncbi.nlm.nih.gov/pubmed/25860834 http://dx.doi.org/10.1021/acs.jmedchem.5b00104 |
Ejemplares similares
-
mCSM: predicting the effects of mutations in proteins using graph-based signatures
por: Pires, Douglas E. V., et al.
Publicado: (2014) -
pdCSM-cancer: Using Graph-Based Signatures to Identify
Small Molecules with Anticancer Properties
por: Al-Jarf, Raghad, et al.
Publicado: (2021) -
kinCSM: Using graph‐based signatures to predict small molecule CDK2 inhibitors
por: Zhou, Yunzhuo, et al.
Publicado: (2022) -
mCSM-lig: quantifying the effects of mutations on protein-small molecule affinity in genetic disease and emergence of drug resistance
por: Pires, Douglas E. V., et al.
Publicado: (2016) -
cropCSM: designing safe and potent herbicides with graph-based signatures
por: Pires, Douglas E V, et al.
Publicado: (2022)